Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
PharmafocusNews Register for New Alert
News for November 2007
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Short sighted pharma undermining its own future, says Oxfam
Lack of focus on drug access holding industry back..(more)

 Sanofi and Regeneron sign antibody deal
Rheumatoid arthritis candidate first to enter trials..(more)

 Ezetrol receives NICE approval
Guidance could see fewer patients switched to more potent statins like Lipitor..(more)

 Latest news from Datamonitor
Drug development roundup..(more)

 European approval for Merck's cyanide antidote
Product will help prevent irreversible neurological injury ..(more)

 Wyeth kidney cancer drug approved in Europe
First in class orphan drug offers new way of treating kidney cancer..(more)

 Ethical dilemma for doctors must be confronted, says bowel cancer charity
Many patients not informed of all treatment options..(more)

 GSK pays $1.65 billion for cardiovascular specialists Reliant
Purchase is one of the biggest pay outs for a specialist player in 2007..(more)

 NHS set for major underspend
Forecast prompts accusations of boom and bust..(more)

 Champix linked to depression and suicidal thoughts
Drug will remain on market while FDA decides on course of action..(more)

 Pfizer buys immune system specialists Coley
Pays $164m to strengthen vaccine strategy..(more)

 Prexige pulled from UK market
MHRA decides urgent action needed ahead of European review..(more)

 Latest news from Datamonitor
Research news in HIV, diabetes and cancer..(more)

 New software aims to cut hospital admissions
Program identifies patients who can be treated in primary care..(more)

 J&J unveils new 'comprehensive care' strategy
New group will combine drug treatment, medical devices and diagnostics..(more)

 Rules on patient groups to change
Pharma has until July 2008 to meet new transparency regulations..(more)

 Private sector schemes axed
But government pushes on with 'pragmatic' use of independent sector..(more)

 Merck to pay $4.9 billion to end Vioxx claims
Massive deal will help cap costs and should draw line under lawsuits..(more)

 Remicade loses out in ankylosing spondylitis
Two rival drugs are judged to be cost-effective..(more)

 GSK scales back US health warnings for Avandia
FDA couldn't find conclusive link to cardiovascular side effects..(more)

 Sanofi and Acambis to collaborate on West Nile virus
Acambis will develop vaccine candidate up to its US filing..(more)

 Slow progress on hospital waiting lists
Key target unlikely to be hit..(more)

 Bayer's Nexavar and Xarelto key to future growth
Company says 2007 is on track to be its best year ever..(more)

 Conservatives renew call for independent NHS
Party will introduce new Bill to remove 'political tinkering'..(more)

 Pharmacy encouraged to play greater clinical role
Lloydspharmacy director appointed to key committee..(more)

 Liver problems delay Galvus launch
Small but significant doubts emerge over safety..(more)

 Latest news from Datamonitor
Company news roundup..(more)

 New leadership study to advance women in pharma
Reveals factors for equality in senior career progression..(more)

 Blood loss drug suspended over safety fears
New data indicates Trasylol could be causing kidney damage..(more)

 Government yet to decide between rival cancer vaccines
Sanofi Pasteur MSD and GSK expected to tender for contract soon..(more)

 NICE rejects arthritis drug Orencia
BMS says decision ignored drug's wider economic benefits..(more)

 Roche maintains sales growth for Q3
Company's growth hits more than twice market average..(more)

 BMA bemoans health service regulator re-think
Says Care Quality Commission represents more upheaval..(more)

 Sales stay sluggish at Sanofi
But strong vaccines performance pulls Q3 results out of the red..(more)

 Generic challenger threatens Crestor
AstraZeneca's patent position had assumed to be secure until 2016..(more)

 Woolley Pau bought by Gyro International
Consumer marketers plan further healthcare deal by Christmas..(more)

 CROs included in clinical trials fast track
Government extends model Clinical Trial Agreement to industry's outsourcing partners..(more)

 Dwindling sales mean job cuts at GSK
Demand for Avandia continues to fall..(more)

 NHS clinical effectiveness taskforce launched
Part of new measures to help NHS use resources and technology..(more)

 Latest news from Datamonitor
Company news roundup..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.